International Biotechnology Trust PLC Uni Qure N.V. Transaction History
International Biotechnology Trust PLC
- $295 Million
- Q3 2023
A detailed history of International Biotechnology Trust PLC transactions in Uni Qure N.V. stock. As of the latest transaction made, International Biotechnology Trust PLC holds 1,241,500 shares of QURE stock, worth $19.5 Million. This represents 2.83% of its overall portfolio holdings.
Number of Shares
1,241,500
Previous 15,500
7909.68%
Holding current value
$19.5 Million
Previous $177,000
4606.21%
% of portfolio
2.83%
Previous 0.06%
Shares
13 transactions
Others Institutions Holding QURE
# of Institutions
152Shares Held
40.4MCall Options Held
925KPut Options Held
617K-
Vestal Point Capital, LP New York, NY4.75MShares$74.8 Million1.78% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.78MShares$43.8 Million0.81% of portfolio
-
Boxer Capital, LLC San Diego, CA2.23MShares$35 Million0.58% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.19MShares$34.5 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.93MShares$30.3 Million0.0% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $736M
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...